Table Of Contents
1 Introduction 11
1.1 Objectives Of The Study 11
1.2 Market Definition 11
1.3 Overview Of Asia-Pacific Pdx Models Market 11
1.4 Currency And Pricing 12
1.5 Limitation 12
1.6 Markets Covered 12
2 Market Segmentation 14
2.1 Markets Covered 14
2.2 Geographic Scope 15
2.3 Years Considered For The Study 15
2.4 Currency And Pricing 16
2.5 Research Methodology 17
2.6 Primary Interviews With Key Opinion Leaders 20
2.7 Secondary Sources 21
2.8 Assumptions 21
3 Market Overview 22
3.1 Drivers 24
3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research 24
3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach 26
3.1.3 Rising Need For Personalized Medicine 27
3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization 27
3.2 Restraints 28
3.2.1 High Cost Of Pdx Models 28
3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research 28
3.3 Opprtunities 29
3.3.1 Increasing Demand For Humanized Pdx Models 29
3.4 Challenges 30
3.4.1 Limitations Of Pdx Models 30
4 Executive Summary 31
5 Premium Insights 33
6 Asia-Pacific Pdx Models Market, By Type 36
6.1 Overview 37
6.2 Mice Models 39
6.3 Rat Models 40
7 Asia-Pacific Pdx Models Market, By Tumor Type 41
7.1 Overview 42
7.2 Gastrointestinal Tumor Models 44
7.3 Gynecological Tumor Models 45
7.4 Respiratory Tumor Models 46
7.5 Urological Tumor Models 47
7.6 Hematological Tumor Models 48
7.7 Others 49
8 Asia-Pacific Pdx Models Market, By Application 50
8.1 Overview 51
8.2 Preclinical Drug Development And Oncology Research 53
8.3 Biomarker Analysis 54
9 Asia-Pacific Pdx Models Market, By End User 55
9.1 Overview 56
9.2 Contract Research Organizations 58
9.3 Pharmaceutical And Biotechnology Companies 59
9.4 Academic And Research Institutions 60
10 Asia-Pacific Pdx Models Market, By Geography 61
10.1 Asia Pacific 61
10.1.1 Japan 70
10.1.2 China 72
10.1.3 India 74
10.1.4 South Korea 76
10.1.5 Australia 78
10.1.6 Singapore 80
10.1.7 Thailand 82
10.1.8 Malaysia 84
10.1.9 Indonesia 87
10.1.10 Philippines 89
10.1.11 Rest Of Asia Pacific 91
11 Asia-Pacific Pdx Models Market, Company Landscape 92
11.1 Company Share Analysis; Asia Pacific 92
12 Company Profiles 93
12.1 Charles River 93
12.1.1 Company Overview 93
12.1.2 Revenue Analysis 93
12.1.3 Company Share Analysis 94
12.1.4 Product Portfolio 94
12.1.5 Recent Developments 94
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation) 95
12.2.1 Company Overview 95
12.2.2 Geographic Presence 95
12.2.3 Company Share Analysis 96
12.2.4 Product Portfolio 96
12.2.5 Recent Developments 97
12.3 Champion Oncology, Inc 98
12.3.1 Company Overview 98
12.3.2 Revenue Analysis 98
12.3.3 Company Share Analysis 99
12.3.4 Product Portfolio 99
12.3.5 Recent Developments 99
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited) 100
12.4.1 Company Overview 100
12.4.2 Product Portfolio 100
12.4.3 Recent Developments 100
12.5 Creative Animodel 101
12.5.1 Company Overview 101
12.5.2 Product Portfolio 101
12.5.3 Recent Developments 101
12.6 Epo Berlin-Buch Gmbh 102
12.6.1 Company Overview 102
12.6.2 Product Portfolio 102
12.6.3 Recent Developments 102
12.7 Europdx 103
12.7.1 Company Overview 103
12.7.2 Geographical Presence 103
12.7.3 Product Portfolio 104
12.7.4 Recent Developments 104
12.8 Hera Biolabs 105
12.8.1 Company Overview 105
12.8.2 Product Portfolio 105
12.8.3 Recent Developments 105
12.9 Horizon Discovery Group Plc 106
12.9.1 Company Overview 106
12.9.2 Revenue Analysis 106
12.9.3 Product Portfolio 107
12.9.4 Recent Developments 107
12.10 Mi Bioresearch Inc 108
12.10.1 Company Overview 108
12.10.2 Product Portfolio 108
12.10.3 Recent Developments 108
12.11 Oncodesign 109
12.11.1 Company Overview 109
12.11.2 Revenue Analysis 109
12.11.3 Product Portfolio 110
12.11.4 Recent Developments 110
12.12 Pharmatest Services Ltd 111
12.12.1 Company Overview 111
12.12.2 Geographic Presence 111
12.12.3 Product Portfolio 112
12.12.4 Recent Developments 112
12.13 The Jackson Laboratory 113
12.13.1 Company Overview 113
12.13.2 Revenue Analysis 113
12.13.3 Product Portfolio 114
12.13.4 Recent Developments 114
12.14 Urolead 115
12.14.1 Company Overview 115
12.14.2 Product Portfolio 115
12.14.3 Recent Developments 115
12.15 Wuxi Apptec 116
12.15.1 Company Overview 116
12.15.2 Geographic Presence 116
12.15.3 Product Portfolio 117
12.15.4 Recent Developments 117
12.16 Xentech 118
12.16.1 Company Overview 118
12.16.2 Product Portfolio 118
12.16.3 Recent Developments 118
13 Related Reports 119